Enhanced UV Technology Improves Hospital Infection Prevention 
|
By HospiMedica International staff writers Posted on 09 Jun 2014 |
|
Image: The TRU-D SmartUVC with iTRU-D in action (Photo courtesy of TRU-D).
An upgraded Ultraviolet C band (UV-C) disinfection robot performs automated pathogen disinfection of patient spaces.
The TRU-D SmartUVC with iTRU-D exploits Sensor360 technology for instant room analysis and dose calculation and delivery, eliminating the need to input room measurements, floor plans or diagrams needed to designate multiple robot positions, and increased labor costs due to the need to cover windows and vents. As a result, the TRU-D is able to disinfect an entire room—including shadowed spaces—from one location within the room, eliminating labor associated with continually moving it to multiple sites inside the room. The disinfection progress also ensures 3–4 log surface disinfection of pathogens in any space.
Cloud-based infection prevention data tracking technology provided by iTRU-D reports concurrent prevention, usage efficiency, and risk aversion data. The secure usage-tracking program also sends customized real-time infection prevention reports via an iPad Mini to hospital staff. Among the other features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows. The TRU-D SmartUVC portable disinfection robot with iTRU-D is a product of TRU-D (Memphis, TN, USA).
“We work closely with our customers to provide a product that fits their infection prevention needs. Second to providing an evidence base for consistent disinfection outcomes to insure patient safety, labor cost is the major consideration in the selection of no-touch room disinfection technology,” said Chuck Dunn, president of TRU-D. “TRU-D is validated by numerous third-party scientific studies proving that TRU-D's patented technology works to eradicate 99.9% of pathogens, which is what's most important to health care customers.”
UV-C light is a UV wavelength of 254 nm that induces the formation of pyrimidine dimers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, thus destroying the organisms or rendering them unable to reproduce. The efficacy of the UV-C irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
Related Links:
TRU-D
The TRU-D SmartUVC with iTRU-D exploits Sensor360 technology for instant room analysis and dose calculation and delivery, eliminating the need to input room measurements, floor plans or diagrams needed to designate multiple robot positions, and increased labor costs due to the need to cover windows and vents. As a result, the TRU-D is able to disinfect an entire room—including shadowed spaces—from one location within the room, eliminating labor associated with continually moving it to multiple sites inside the room. The disinfection progress also ensures 3–4 log surface disinfection of pathogens in any space.
Cloud-based infection prevention data tracking technology provided by iTRU-D reports concurrent prevention, usage efficiency, and risk aversion data. The secure usage-tracking program also sends customized real-time infection prevention reports via an iPad Mini to hospital staff. Among the other features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows. The TRU-D SmartUVC portable disinfection robot with iTRU-D is a product of TRU-D (Memphis, TN, USA).
“We work closely with our customers to provide a product that fits their infection prevention needs. Second to providing an evidence base for consistent disinfection outcomes to insure patient safety, labor cost is the major consideration in the selection of no-touch room disinfection technology,” said Chuck Dunn, president of TRU-D. “TRU-D is validated by numerous third-party scientific studies proving that TRU-D's patented technology works to eradicate 99.9% of pathogens, which is what's most important to health care customers.”
UV-C light is a UV wavelength of 254 nm that induces the formation of pyrimidine dimers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, thus destroying the organisms or rendering them unable to reproduce. The efficacy of the UV-C irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
Related Links:
TRU-D
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Vessel Sealing Instrument
ERGOseal
New
Wound Irrigation Solution
Prontosan®
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
